SPRY DEADLINE: Levi & Korsinsky Reminds ARS Pharmaceuticals Inc. Investors of Upcoming Securities Class Action Deadline
A securities class action alleges ARS Pharmaceuticals overstated its progress toward removing prior authorization barriers with CVS Caremark, the last major PBM standing between neffy and unrestricted commercial access. NEW YORK, Sept. 16, 2026 /PRNewswire/ -- Levi & Korsinsky, LLP...
Covered in this story
What has happened since
- Ars Pharmaceuticals Inc is up 3.7% since this was published, 36 days ago.
- CVS Health is up 3.0% since this was published, 36 days ago.
Price move measured from the close nearest publication to the latest quote.
Call it yourself
No calls on $SPRY yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Ars Pharmaceuticals Inc →Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.